Literature DB >> 2542588

Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.

B Contreras-Salazar1, G Klein, M G Masucci.   

Abstract

We have analyzed the expression of the three major known growth transformation-associated Epstein-Barr virus (EBV) proteins, EBNA-1, EBNA-2, and latent membrane protein (LMP), in a series of somatic cell hybrids derived from the fusion of EBV-carrying Burkitt lymphoma (BL) lines with EBV-positive or EBV-negative B-cell lines. Independently of the cell phenotype, EBNA-1 was invariably coexpressed in all EBV-carrying hybrids. In hybrids between EBV-carrying, LMP-positive and LMP-negative Burkitt lymphoma lines, LMP was expressed, indicating positive control. Two EBV-negative lymphoma lines, Ramos and BJAB, differed in their ability to express LMP after B95-8 virus-induced conversion and after hybridization with Raji cells. BJAB was permissive while Ramos was nonpermissive for LMP, although both expressed EBNA-2. The EBNA-2-deleted P3HR-1 virus gave the same pattern of LMP expression in these two cells. Our findings indicate that the expression of EBNA-1, EBNA-2, and LMP is regulated by independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542588      PMCID: PMC250775     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.

Authors:  A Ricksten; B Kallin; H Alexander; J Dillner; R Fåhraeus; G Klein; R Lerner; L Rymo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.

Authors:  D A Thorley-Lawson; E S Israelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures.

Authors:  Y Hinuma; J T Grace
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

4.  Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.

Authors:  D J Moss; I S Misko; S R Burrows; K Burman; R McCarthy; T B Sculley
Journal:  Nature       Date:  1988-02-25       Impact factor: 49.962

5.  Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.

Authors:  V R Baichwal; B Sugden
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

6.  A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes.

Authors:  L Petti; J Sample; F Wang; E Kieff
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

Authors:  R Fåhraeus; H L Fu; I Ernberg; J Finke; M Rowe; G Klein; K Falk; E Nilsson; M Yadav; P Busson
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

8.  Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.

Authors:  R J Murray; D Wang; L S Young; F Wang; M Rowe; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line.

Authors:  S Torsteinsdóttir; M L Andersson; J Avila-Cariño; B Ehlin-Henriksson; M G Masucci; G Klein; E Klein
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

10.  Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

Authors:  M Rowe; D T Rowe; C D Gregory; L S Young; P J Farrell; H Rupani; A B Rickinson
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  5 in total

1.  Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.

Authors:  E Altiok; J Minarovits; L F Hu; B Contreras-Brodin; G Klein; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

2.  Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.

Authors:  R Fåhraeus; A Jansson; A Ricksten; A Sjöblom; L Rymo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.

Authors:  B Contreras-Salazar; B Ehlin-Henriksson; G Klein; M G Masucci
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

4.  The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.

Authors:  K Kanda; T Decker; P Aman; M Wahlström; A von Gabain; B Kallin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

5.  A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.

Authors:  F Chen; J Z Zou; L di Renzo; G Winberg; L F Hu; E Klein; G Klein; I Ernberg
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.